Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ContraFect Corporation CFRX
$1.50
-$0.1 (-6.83%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
6055368.00000000
-
week52high
363.20
-
week52low
0.90
-
Revenue
0
-
P/E TTM
0
-
Beta
0.43044900
-
EPS
-972.44000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 12:30
Описание компании
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also initiated an expanded access program to provide Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Market Perform | Outperform | 14 июл 2022 г. |
| Maxim Group | Hold | Buy | 14 июл 2022 г. |
| Cantor Fitzgerald | Neutral | Overweight | 14 июл 2022 г. |
| WBB Securities | Strong Buy | Buy | 08 июн 2022 г. |
| SVB Leerink | Outperform | Outperform | 16 февр 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Barlow Jane F | A | 42000 | 42000 | 17 мая 2022 г. |
| Sucoff Cary | A | 42000 | 42000 | 17 мая 2022 г. |
| OTTO MICHAEL J. | A | 42000 | 42000 | 17 мая 2022 г. |
| Low David N. | A | 42000 | 42000 | 17 мая 2022 г. |
| GILMAN STEVEN C | A | 42000 | 42000 | 17 мая 2022 г. |
| BARER SOL J | A | 42000 | 42000 | 17 мая 2022 г. |
| Aklog Lishan | A | 42000 | 42000 | 17 мая 2022 г. |
| Pomerantz Roger | A | 500000 | 500000 | 15 февр 2022 г. |
| Messinger Michael | A | 165000 | 165000 | 15 февр 2022 г. |
| Cassino Cara M | A | 160000 | 160000 | 15 февр 2022 г. |
Новостная лента
Discover the Top Penny Stock Technical Indicators By Effectiveness
PennyStocks
28 апр 2023 г. в 06:00
Use these technical indicators to profit with penny stocks The post Discover the Top Penny Stock Technical Indicators By Effectiveness appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is ContraFect (CFRX) Stock Down 14% Today?
InvestorPlace
18 апр 2023 г. в 09:05
ContraFect (NASDAQ: CFRX ) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange. That notice has to do with the continued listing of CFRX stock on the exchange.
The Future of Buying Penny Stocks: Trends for 2023
PennyStocks
18 апр 2023 г. в 07:00
Use these tips to invest in penny stocks right now The post The Future of Buying Penny Stocks: Trends for 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stock Investing for Passive Income: Opportunities and Risks
PennyStocks
28 февр 2023 г. в 06:00
Use these tips for making passive income with penny stocks The post Penny Stock Investing for Passive Income: Opportunities and Risks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is ContraFect (CFRX) Stock Up 20% Today?
InvestorPlace
31 янв 2023 г. в 08:27
ContraFect (NASDAQ: CFRX ) stock is rising higher on Tuesday as investors await news about its potential delisting from the Nasdaq Capital Market. ContraFect last updated investors on Friday about its delisting situation.